A Phase I Trial Assessing The Feasibility Of Romidepsin Combined With Brentuximab Vedotin For Patients Requiring Systemic Therapy For Cutaneous T-Cell LymphomaStefan K. Barta,Tatyana A. Feldman,Jennifer A. DeSimone,Ellen Kim, Karthik Devajaran,David Wiest,Henry C.H. Fung,Richard I. Fisher,Carlyn Tan,Nadia KhanBLOOD(2020)引用 2|浏览16暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要